Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 16
Clinical Trial Report
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,870 | Dovepress* | 1,732+ | 52 | 1,784 | |
| PubMed Central* | 138 | 28 | 166 | ||
| Totals | 1,870 | 80 | 1,950 | ||
| *Since 12 April 2024 | |||||
View citations on PubMed Central and Google Scholar